David Mehalick - 11 Feb 2026 Form 4 Insider Report for Coeptis Therapeutics Holdings, Inc. (COEP)

Role: CEO and President, Director, 10%+ Owner
Signature: /s/ David Mehalick
Issuer symbol: COEP
Transactions as of: 11 Feb 2026
Net transactions value: +$1,049,569
Form type: 4
Filing time: 13 Feb 2026, 17:00:09 UTC
Previous filing: 06 Mar 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Mehalick David	CEO and President, Director, 10%+ Owner	105 BRADFORD RD, SUITE 420, WEXFORD	/s/ David Mehalick	13 Feb 2026	0001846623

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	COEP	Common stock	Options Exercise	$1,049,569	+148,875	+82%	$7.05	330,192	11 Feb 2026	Direct	F1
transaction	COEP	Common Stock	Award	$0	+51,250	+18%	$0.000000	330,192	11 Feb 2026	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the weighted average exercise price of shares purchased upon exercise of stock options.
F2	Represents a grant of restricted stock issued in connection with an option exchange program where the Reporting Person surrendered underwater options in exchange for a grant of restricted stock.